Saturday, 5 September 2026European Markets

ELMERA GROUP And MAGNORA Have A High Dividend Yield And Return On Equity In The Utilities Sector.

Loading stream...

(VIANEWS) - ELMERA GROUP (ELMRA.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Utilities sector.

Financial Asset Price Forward Dividend Yield Return on Equity
ELMERA GROUP (ELMRA.OL) kr24.70 6.79% 5.02%
MAGNORA (MGN.OL) kr31.75 1.18% 52.28%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ELMERA GROUP (ELMRA.OL)

6.79% Forward Dividend Yield and 5.02% Return On Equity

Elmera Group ASA, together with its subsidiaries, engages in the purchase, sale, and portfolio management of electrical power to households, private and public companies, and municipalities in Norway. It operates through Consumer, Business, and Nordic segments. The Consumer segment sells electrical power and related services to private consumers. The Business segment sells electrical power and related services to business consumers. The Nordic segment sells electrical power and related services to consumers in Finland and Sweden. The company also manages, researches, and develops products and services related to electrical power; and offers payment solutions. In addition, it provides mobile phone services to private customers. The company was formerly known as Fjordkraft Holding ASA and changed its name to Elmera Group ASA in April 2022. Elmera Group ASA was founded in 2001 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, ELMERA GROUP has a trailing twelve months EPS of kr0.56.

PE Ratio

ELMERA GROUP has a trailing twelve months price to earnings ratio of 44.11. Meaning, the purchaser of the share is investing kr44.11 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.02%.

Growth Estimates Quarters

The company's growth estimates for the current quarter is a negative 70.9% and positive 500% for the next.

More news about ELMERA GROUP.

2. MAGNORA (MGN.OL)

1.18% Forward Dividend Yield and 52.28% Return On Equity

Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, MAGNORA has a trailing twelve months EPS of kr4.01.

PE Ratio

MAGNORA has a trailing twelve months price to earnings ratio of 7.92. Meaning, the purchaser of the share is investing kr7.92 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 52.28%.

Sales Growth

MAGNORA's sales growth for the next quarter is negative 69.1%.

More news about MAGNORA.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com